CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

The Unique Challenges and Opportunities of Forecasting for Orphan Diseases

The term rare, or orphan disease can encompass any one of more than 6000 conditions. Some, such as cystic fibrosis or Tourette’s syndrome, are well known, while others, including Acromegaly or Morquio syndrome, are much less well recognised. David James at J+D Forecasting delves into history, showing how historically, patients diagnosed with a disease classified as rare were denied access to effective medicines because prescription drug manufacturers could rarely make a profit from marketing drugs to such small groups.

 

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026